150 related articles for article (PubMed ID: 11694217)
1. Early pharmacologic intervention and plaque stability in acute coronary syndromes.
Waters DD
Am J Cardiol; 2001 Oct; 88(8A):30K-36K. PubMed ID: 11694217
[TBL] [Abstract][Full Text] [Related]
2. [Should we begin with statin therapy in acute coronary syndrome?].
Reiner Z
Acta Med Croatica; 2004; 58(2):147-50. PubMed ID: 15208802
[TBL] [Abstract][Full Text] [Related]
3. Acute statin treatment in reducing risk after acute coronary syndrome: the MIRACL (Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering) Trial.
Ahsan CH; Shah A; Ezekowitz M
Curr Opin Cardiol; 2001 Nov; 16(6):390-3. PubMed ID: 11704711
[TBL] [Abstract][Full Text] [Related]
4. Statin lipid-lowering therapy for acute myocardial infarction and unstable angina: efficacy and mechanism of benefit.
Wright RS; Murphy JG; Bybee KA; Kopecky SL; LaBlanche JM
Mayo Clin Proc; 2002 Oct; 77(10):1085-92. PubMed ID: 12374252
[TBL] [Abstract][Full Text] [Related]
5. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
Kinlay S; Schwartz GG; Olsson AG; Rifai N; Leslie SJ; Sasiela WJ; Szarek M; Libby P; Ganz P;
Circulation; 2003 Sep; 108(13):1560-6. PubMed ID: 12975259
[TBL] [Abstract][Full Text] [Related]
6. Calming the plaque to delay intervention for 24 hours in acute coronary syndromes.
Cohen M
Am J Cardiol; 2000 Dec; 86(12B):18M-26M. PubMed ID: 11206014
[TBL] [Abstract][Full Text] [Related]
7. What is the role of intensive cholesterol lowering in the treatment of acute coronary syndromes?
Waters DD; Hsue PY
Am J Cardiol; 2001 Oct; 88(7B):7J-16J. PubMed ID: 11595193
[TBL] [Abstract][Full Text] [Related]
8. Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction.
Schwartz GG; Oliver MF; Ezekowitz MD; Ganz P; Waters D; Kane JP; Texter M; Pressler ML; Black D; Chaitman BR; Olsson AG
Am J Cardiol; 1998 Mar; 81(5):578-81. PubMed ID: 9514453
[TBL] [Abstract][Full Text] [Related]
9. The early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial: a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndrome--study design and rationale.
Giugliano RP; Newby LK; Harrington RA; Gibson CM; Van de Werf F; Armstrong P; Montalescot G; Gilbert J; Strony JT; Califf RM; Braunwald E;
Am Heart J; 2005 Jun; 149(6):994-1002. PubMed ID: 15976780
[TBL] [Abstract][Full Text] [Related]
10. Is there a true beneficial effect of statin therapy in the acute phase of unstable angina or myocardial infarction?
Correia LC
Curr Vasc Pharmacol; 2007 Jul; 5(3):221-5. PubMed ID: 17627565
[TBL] [Abstract][Full Text] [Related]
11. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study.
Kinlay S; Schwartz GG; Olsson AG; Rifai N; Sasiela WJ; Szarek M; Ganz P; Libby P;
Circulation; 2004 Jul; 110(4):386-91. PubMed ID: 15262833
[TBL] [Abstract][Full Text] [Related]
12. The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes.
Ray KK; Cannon CP
J Am Coll Cardiol; 2005 Oct; 46(8):1425-33. PubMed ID: 16226165
[TBL] [Abstract][Full Text] [Related]
13. Early initiation of treatment with statins in acute coronary syndromes.
Olsson AG; Schwartz GG
Ann Med; 2002; 34(1):37-41. PubMed ID: 12014432
[TBL] [Abstract][Full Text] [Related]
14. Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapy.
Rosenson RS
Am J Cardiovasc Drugs; 2001; 1(6):411-20. PubMed ID: 14728000
[TBL] [Abstract][Full Text] [Related]
15. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials).
Murphy SA; Cannon CP; Wiviott SD; de Lemos JA; Blazing MA; McCabe CH; Califf RM; Braunwald E
Am J Cardiol; 2007 Oct; 100(7):1047-51. PubMed ID: 17884359
[TBL] [Abstract][Full Text] [Related]
16. Medical therapy of unstable angina and non-Q-wave myocardial infarction.
Abrams J
Am J Cardiol; 2000 Oct; 86(8B):24J-33J; discussion 33J-34J. PubMed ID: 11081446
[TBL] [Abstract][Full Text] [Related]
17. Early statin therapy in acute coronary syndromes.
Kinlay S
Minerva Cardioangiol; 2003 Oct; 51(5):577-84. PubMed ID: 14551525
[TBL] [Abstract][Full Text] [Related]
18. Should intensive cholesterol lowering play a role in the management of acute coronary syndromes?
Waters DD; Azar RR
Am J Cardiol; 2000 Oct; 86(8B):35J-42J; discussion 42J-43J. PubMed ID: 11081447
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design of the Myocardial Ischemia Reduction With Aggressive Cholesterol lowering (MIRACL) Study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction.
Ghali JK
Am J Cardiol; 1998 Sep; 82(5):703. PubMed ID: 9732912
[No Abstract] [Full Text] [Related]
20. Antiplatelet intervention in acute coronary syndrome.
Arora RR; Rai F
Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
